In 2021, Shi et al. added the PET ligand APN-1607 to sarkosyl-insoluble tau filaments from the frontal cortex of an AD patient, in order to identify the binding hot-spot of the ligand [36]. This evidence concerns the gene MAPT and Alzheimer disease.